ロード中...
A tetravalent alphavirus-vector based Dengue vaccine provides effective immunity in an early life mouse model
Dengue viruses (DENV1-4) cause 390 million clinical infections every year, several hundred thousand of which progress to severe hemorrhagic and shock syndromes. Preexisting immunity resulting from a previous DENV infection is the major risk factor for severe dengue during secondary heterologous infe...
保存先:
| 出版年: | Vaccine |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4487803/ https://ncbi.nlm.nih.gov/pubmed/24882043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.05.053 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|